Why the study?
Do different revascularization approaches (such as ONCABG and RCAB) reduce TVR and postoperative complications in patients with multi-vessel coronary artery disease?
Do different revascularization approaches (such as ONCABG and RCAB) reduce TVR and postoperative complications in patients with multi-vessel coronary artery disease?
In a network meta-analysis of non-randomized studies, ONCABG ranked best for preventing TVR, whereas RCAB was associated with fewer postoperative complications for patients with multi-vessel CAD.
Answers are grounded in this paper and cite their sources.
May inform technique selection in multi-vessel CAD; leaves open confirmation by randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hasan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: